Plexus Corp. (NASDAQ:PLXS) Insider Steven J. Frisch Sells 700 Shares

Plexus Corp. (NASDAQ:PLXS) insider Steven J. Frisch sold 700 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $108.19, for a total value of $75,733.00. Following the sale, the insider now owns 56,113 shares of the company’s stock, valued at approximately $6,070,865.47. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Plexus Price Performance

Shares of PLXS stock traded up $0.62 during trading on Wednesday, hitting $107.04. The company had a trading volume of 78,819 shares, compared to its average volume of 120,473. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.64 and a current ratio of 1.51. The firm has a market capitalization of $2.95 billion, a P/E ratio of 29.57 and a beta of 1.00. The stock’s 50-day moving average price is $95.76 and its 200 day moving average price is $98.96. Plexus Corp. has a one year low of $85.35 and a one year high of $114.06.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, April 24th. The technology company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.07. Plexus had a return on equity of 10.77% and a net margin of 2.54%. The firm had revenue of $966.90 million during the quarter, compared to analysts’ expectations of $950.75 million. During the same period in the prior year, the company earned $1.45 earnings per share. The company’s quarterly revenue was down 9.7% on a year-over-year basis. Equities analysts expect that Plexus Corp. will post 3.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Benchmark restated a “buy” rating and set a $110.00 price objective on shares of Plexus in a report on Wednesday, January 17th. Stifel Nicolaus boosted their price objective on Plexus from $90.00 to $95.00 and gave the stock a “hold” rating in a report on Friday, April 26th. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $112.00 price objective for the company. in a report on Tuesday, January 9th. Needham & Company LLC boosted their price target on Plexus from $107.00 to $114.00 and gave the company a “buy” rating in a research note on Friday, April 26th. Finally, TheStreet cut Plexus from a “b” rating to a “c+” rating in a research note on Tuesday, February 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Plexus has a consensus rating of “Hold” and a consensus price target of $107.75.

Institutional Investors Weigh In On Plexus

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Plexus by 1.4% during the third quarter. Vanguard Group Inc. now owns 3,453,940 shares of the technology company’s stock worth $321,147,000 after purchasing an additional 47,762 shares during the last quarter. Fiduciary Management Inc. WI lifted its stake in Plexus by 3.8% during the fourth quarter. Fiduciary Management Inc. WI now owns 1,226,917 shares of the technology company’s stock worth $132,667,000 after purchasing an additional 44,398 shares during the last quarter. BNP Paribas Asset Management Holding S.A. increased its holdings in shares of Plexus by 0.9% during the fourth quarter. BNP Paribas Asset Management Holding S.A. now owns 954,853 shares of the technology company’s stock worth $103,248,000 after buying an additional 8,243 shares in the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Plexus by 0.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 484,095 shares of the technology company’s stock worth $45,011,000 after buying an additional 3,459 shares in the last quarter. Finally, Boston Trust Walden Corp increased its holdings in shares of Plexus by 1.1% during the fourth quarter. Boston Trust Walden Corp now owns 402,382 shares of the technology company’s stock worth $43,510,000 after buying an additional 4,500 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.